The startup produces a patented portable in vitro diagnostic device that provides rapid analysis for blood-type, sub-type, diseases, and nutrients.
Criam has raised €1.9M across 1 funding round from 4 investors, most recently a Seed round in Nov 2021. Based in Braga, Portugal; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-24 | Seed | €1.9M |
| Artesian VC,European Innovation Council (EIC),Social Impact Fund,SOSV |
| View deal → |
